Fennec Pharmaceuticals (FENC) Non-Current Assets (2019 - 2025)
Fennec Pharmaceuticals posted quarterly Non-Current Assets of $3.5 million for Q4 2025, up 326.76% year-on-year from $822000.0 in Q4 2024, and up 9.73% on a QoQ basis from $3.2 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 7 years of Non-Current Assets data on file, last reported at $3.5 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Assets rose 326.76% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (up 326.76% YoY), and the FY2025 full-year result was $3.5 million, up 326.76% from the prior year.
- Non-Current Assets for Q4 2025 stood at $3.5 million, up from $3.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $4.1 million in Q2 2025 and bottomed at $6000.0 in Q4 2023.
- The 5-year median for Non-Current Assets is $211000.0 (2022), against an average of $998421.1.
- The widest annual swing landed in 2023, when Non-Current Assets tumbled 97.16%; it then soared 13600.0% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $27000.0 in 2021, then soared by 681.48% to $211000.0 in 2022, then sank by 97.16% to $6000.0 in 2023, then jumped by 13600.0% to $822000.0 in 2024, then soared by 326.76% to $3.5 million in 2025.
- The last three Non-Current Assets figures came in at $3.5 million (Q4 2025), $3.2 million (Q3 2025), and $4.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 956,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Jun 30, 2020 | 417,000.00 |
| Mar 31, 2020 | 245,000.00 |
| Dec 31, 2019 | 262,000.00 |
| Sep 30, 2019 | 280,000.00 |
| Jun 30, 2019 | 297,000.00 |
| Mar 31, 2019 | 314,000.00 |